David Beno PhD

Dr. David Beno is the CSO of Xeno Biosciences. He brings over 33 years of diverse business and scientific expertise to Xeno Biosciences. He is a passionate advocate of the importance of the microbiome in health, a steadfast belief seeded in 1984 when he began his graduate degrees in Microbiology and Immunology at Loyola Medical Center of Chicago. Next, David held academic appointments in GI/Nutrition at the University of Chicago and then in Neonatology at Rush Medical Center.

He then joined Abbott Laboratories in drug discovery and development, where he was responsible for facilitating team strategies for program design, pharmacokinetics, and regulatory filings across 5 therapeutic areas including hepatology, GI & metabolism. David later moved to business development roles for the Abbott Nutrition division, where he most recently served as the New Ventures- External Sourcing Lead, before joining Xeno. The combination of successful programs at Abbott combined with David's academic career has resulted in +85 peer-reviewed publications with +1800 citations, numerous grants and successful NDA and IND filings.